Rights Issue 2022

Preferential rights
The ones who are registered as a shareholder in the share register maintained by Euroclear on behalf of the Company on the record date, September 30, has preferential rights to subscribe for new shares in relation to the number of shares held on the record date.

Each share held on the record date entitles the shareholder to one (1) subscription right. One (1) subscription right entitles subscription for two (2) new shares.

Offering Size
A maximum of 42,099,960 shares, corresponding to approximately 54,7 million SEK.

Offer price
SEK 1.30 per share. Brokerage fee is not charged.

Record date
The record date at Euroclear for determining who has the right to receive subscription rights in the Rights Issue is September 30, 2022. The last day for trading in the Company’s shares including the right to receive subscription rights in the Rights Issue is September 28, 2022. First day of trading in the Company’s shares excluding rights to obtain subscription rights in the Rights Issue is 29 September 2022.

Subscription period
Subscription of new shares with the support of subscription rights must take place by means of a simultaneous cash payment during the period from October 4, 2022 to October 18, 2022. During this period, notification of the subscription of shares can also be made without the support of subscription rights. The Board of Directors of the Company reserves the right to extend the subscription period, which, if relevant, will be announced by the Company via press release no later than the last day of the subscription period, October 18, 2022. The press release will be available on Neola Medical’s website, https://www.neolamedical.se/.

Trading in subscription rights
Trading in subscription rights takes place on Nasdaq First North Growth Market during the period from October 4, 2022 to October 13, 2022 under the ticker NEOLA TR. The ISIN code for the subscription rights is SE0018689044. Shareholders must apply directly to their bank or other administrator with the necessary permission to carry out the purchase and sale of subscription rights. Subscription rights that are not intended to be used for subscription in the Rights Issue must be sold no later than 13 October 2022 or used for subscription of shares no later than 18 October 2022 in order not to become invalid and lose their value. Upon sale of subscription rights, both primary and subsidiary subscription rights are transferred to the new holder of the subscription right. Subscription rights which are acquired during the aforementioned trading period give, during the subscription period, the same right to subscribe for new shares as the subscription rights shareholders receive based on their holdings in the Company on the record date.

Unused subscription rights
Subscription rights which have not been sold by October 13, 2022 at the latest or been used to subscribe for shares by October 18, 2022 at the latest will be booked from all VP accounts without compensation. No special notification takes place when subscription rights are cancelled.

Trade with BTA
Trading in BTA will take place on the Nasdaq First North Growth Market from October 4th until the Swedish Companies Registration Office (Bolagsverket) has registered the Rights Issue and BTA has been converted into shares, which is expected to take place around week 45. Securities institutions with the necessary permits are at your service with buying and selling BTA.

The Rights Issue means, if fully subscribed, that the number of shares in the Company increases from 21,049,980 shares to 63,149,940 shares, which corresponds to a dilution of approximately 67 percent of the total number of shares.